FDCNSEFDC Limited· PharmaceuticalsMediumNeutral
Announced Fri, 20 Mar · 18:50 IST

FDC Limited has informed the Exchange regarding 'General Update'.

Management Changes View source PDF

FDC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹333.15
prior close
₹330.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.7-0.8-0.9-0.1-0.8-4.0-3.6-1.6+1.6+7.1+11.4+10.5+25.2
Up moveDown movePending
AI summary

FDC Limited has reconstituted its Board Committees — Audit, Nomination & Remuneration, and CSR — effective April 1, 2026. The change follows the completion of tenure of CA Uday Kumar Gurkar, who served as Independent Director and Chairman of the Board. Consequently, Mr. Mohan Chandavarkar, the current Managing Director, will be re-designated as Chairman & Managing Director from the same date. The Audit Committee will now be chaired by CA Vijay Maniar, the NRC by Dr. Mahesh Bijlani, and the CSR Committee by Mr. Mohan Chandavarkar. The other committee members are all existing directors continuing in their roles.

Likely market impact

This is a routine governance update following the planned end of an independent chairman's tenure. However, combining the Chairman and Managing Director roles in one person concentrates board authority, which minority shareholders and governance-focused investors typically view with caution. The stock is unlikely to see a major reaction unless the company announces a replacement independent director soon.